No CFDA/SAMR, no Chinese market share. That's the fate for all infant formula companies.
If BAL were lodging their CFDA application earlier, their share price would be in a much higher level.
For WHA & BUB, both are in the similar category, speculative early stage players.
BUB, has its own merits, more revenue, and especially acquiring recognised brand, CapriLac adult goat milk powder, but it's targeting a nitche market - goat infant formula (about 10% of the total infant formula size), and late to lodge SAMR/CFDA application.
To sell into Chinese market, it's not just via Daigou, there are different options, distribution agreements and marketing probably are two keys to be successful, imo.
- Forums
- ASX - By Stock
- whats going on
No CFDA/SAMR, no Chinese market share. That's the fate for all...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
0.010(8.33%) |
Mkt cap ! $116.1M |
Open | High | Low | Value | Volume |
12.5¢ | 13.5¢ | 12.5¢ | $669.0K | 5.144M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 522245 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 668951 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 517245 | 0.130 |
11 | 936931 | 0.125 |
36 | 3132450 | 0.120 |
56 | 2869519 | 0.115 |
38 | 926409 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 209814 | 6 |
0.140 | 513522 | 18 |
0.145 | 1074825 | 11 |
0.150 | 788151 | 22 |
0.155 | 844854 | 14 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |